Company Search:
Advanced Search
Sponsored Links
Novo Nordisk As Company Snapshot
Novo Nordisk As operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Novo Nordisk As with three other pharmaceutical manufacturers in Europe: AstraZeneca PLC of the United Kingdom (2015 sales of £16.20 billion [US$19.52 billion] of which 100% was Pharmaceuticals), Shire PLC of the United Kingdom (£4.21 billion [US$5.07 billion] of which 100% was Pharmaceuticals & Genetic Therapies), and Merck KGaA which is based in Germany (12.84 billion Euro [US$13.62 billion] of which 54% was Healthcare).

Sales Analysis. During the year ended December of 2015, sales at Novo Nordisk As were 107.93 billion Danish Kroner (US$15.38 billion). This is an increase of 21.5% versus 2014, when the company's sales were 88.81 billion Danish Kroner. This was the fifth consecutive year of sales increases at Novo Nordisk As (and since 2010, sales have increased a total of 78%). Sales of Diabetes Care saw an increase of 22.3% in 2015, from 69.98 billion Danish Kroner to 85.59 billion Danish Kroner.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Novo Nordisk As
  Stock Performance Chart for Novo Nordisk As
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 250.30
(Figures in Danish Kroner)
1 Week -2.6%   13 Weeks -2.0%  
4 Weeks -7.5%   52 Weeks -30.7%  
Novo Nordisk As Key Data:
  Ticker: NOVOB Country: Denmark
  Exchanges: CPH OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 107,927,000,000
(Year Ending Jan 2016).
Employees: 40,638
  Currency: Danish Kroner Market Cap: 650,237,173,639
  Fiscal Yr Ends: December Shares Outstanding: 2,597,831,297
  Share Type: B Stamaktie Closely Held Shares: 701,250,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.